首页 | 本学科首页   官方微博 | 高级检索  
     

柚皮苷对人肺癌顺铂耐药株A549/DDP细胞的逆转作用
引用本文:崔美英,贺红柳,李盼,毛颖. 柚皮苷对人肺癌顺铂耐药株A549/DDP细胞的逆转作用[J]. 中国病理生理杂志, 2019, 35(3): 466-472. DOI: 10.3969/j.issn.1000-4718.2019.03.001
作者姓名:崔美英  贺红柳  李盼  毛颖
作者单位:郑州大学第一附属医院病理科, 河南 郑州 450052
摘    要:目的:探究柚皮苷(naringin,NRG)对人肺癌A549/DDP细胞顺铂耐药性的影响及其可能的分子机制。方法:采用CCK-8法检测柚皮苷和顺铂对A549/DDP细胞的毒性作用,采用Chou-Talalay中效分析法对两药的联合效应进行评价;采用流式细胞术检测细胞凋亡;采用Western blot法检测P-糖蛋白(P-glycoprotein,P-gp)、多药耐药相关蛋白1(multidrug resistance-associated protein 1,MRP1)、p-Akt、CXC趋化因子受体4(CXC chemokine receptor 4, CXCR4)、Bcl-2、Bax和cleaved caspase-3的蛋白水平。结果:顺铂耐药株A549/DDP细胞中P-gp、MRP1、p-Akt和CXCR4蛋白的水平显著高于非顺铂耐药株A549细胞(P0.05);柚皮苷和顺铂可剂量依赖性地抑制A549/DDP细胞活力(P0.05),IC_(50)分别为36.92μmol/L和129.77μmol/L;当抑制率超过15%时,二者联用呈协同效应;柚皮苷与顺铂可诱导A549/DDP细胞凋亡(P0.05),并且两药联用组的细胞凋亡率高于顺铂组(P0.05);柚皮苷和顺铂可上调Bax和cleaved caspase-3的蛋白水平(P0.05),下调Bcl-2的蛋白水平(P0.05),同时柚皮苷还可剂量依赖性地下调P-gp、MRP1、p-Akt和CXCR4的蛋白水平(P0.05)。结论:柚皮苷可增强人肺癌A549/DDP细胞对顺铂的敏感性。这可能与柚皮苷上调Bax的蛋白水平,下调Bcl-2、P-gp、MRP1、p-Akt和CXCR4的蛋白水平有关。

关 键 词:柚皮苷  顺铂  肺癌  细胞凋亡  耐药性  
收稿时间:2018-04-02

Reversing effect of naringin on cisplatin resistance in human lung cancer A549/DDP cells
CUI Mei-ying,HE Hong-liu,LI Pan,MAO Ying. Reversing effect of naringin on cisplatin resistance in human lung cancer A549/DDP cells[J]. Chinese Journal of Pathophysiology, 2019, 35(3): 466-472. DOI: 10.3969/j.issn.1000-4718.2019.03.001
Authors:CUI Mei-ying  HE Hong-liu  LI Pan  MAO Ying
Affiliation:Department of Pathology, First Affiliated Hospital of Zhengzhou University, Zhengzhou 450052, China
Abstract:AIM: To investigate the effect of naringin (NRG) on cisplatin (DDP) resistance in human lung cancer A549/DDP cells and its possible mechanism. METHODS: A549/DDP cells were cultured in vitro and treated with NRG and/or DDP at different concentrations for 24 h, and then the cell viability were measured by CCK-8 assay. The combination index (CI) of NRG and DDP were analyzed by Chou-Talalay method. The apoptosis rate was analyzed by flow cytometry. Western blot was performed to detect the protein levels of P-glycoprotein (P-gp), multidrug resistance-associated protein 1 (MRP1), p-Akt, CXC chemokine receptor 4 (CXCR4), cleaved caspase-3, Bcl-2 and Bax.RESULTS: The protein levels of P-gp, MRP1, p-Akt and CXCR4 in the A549/DDP cells were higher than those in the A549 cells (P<0.05). The cell viability was remarkably reduced in a dose-dependent manner when A549/DDP cells were exposed to NRG and/or DDP (P<0.05), and the IC50 values of NRG and DDP were 36.92 μmol/L and 129.77 μmol/L, respectively. When the inhibition rate exceeded 15%, NRG in combination with DDP produced a synergistic effect (CI<1). Combination treatment with NRG and DDP significantly induced apoptosis (P<0.05), up-regulated the protein levels of cleaved caspase-3 and Bax, and down-regulated the protein level of Bcl-2 (P<0.05). Meanwhile, NRG remarkably down-regulated the protein levels of P-gp, MRP1, p-Akt and CXCR4 in a dose-dependent manner (P<0.05). CONCLUSION: NRG may enhance the sensibility of A549/DDP cells to DDP most likely via up-regulating the protein level of Bax and down-regulating the protein levels of Bcl-2, P-gp, MRP1, p-Akt and CXCR4.
Keywords:Naringin  Cisplatin  Lung cancer  Apoptosis  Drug resistance
本文献已被 CNKI 等数据库收录!
点击此处可从《中国病理生理杂志》浏览原始摘要信息
点击此处可从《中国病理生理杂志》下载免费的PDF全文
设为首页 | 免责声明 | 关于勤云 | 加入收藏

Copyright©北京勤云科技发展有限公司  京ICP备09084417号